50I.F HYGEIA HC HLDGS DL-00001
- Market cap
- -
- P/E
- -
- P/B
- 0.70x
- ROE
- 2.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 50I.F undervalued?
Graham numberThe Graham number of HYGEIA HC HLDGS DL-00001 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HYGEIA HC HLDGS DL-00001 fundamental analysis
No fundamental analysis for HYGEIA HC HLDGS DL-00001 yet.
HYGEIA HC HLDGS DL-00001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HYGEIA HC HLDGS DL-00001
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital management…
Full company profileHYGEIA HC HLDGS DL-00001 financial statements
HYGEIA HC HLDGS DL-00001 annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | - | 2.32B | 3.20B | 4.08B | 4.45B | 4.01B |
| Gross Profit | - | - | 757M | 1.03B | 1.29B | 1.33B | 1.02B |
| Operating Income | - | - | 524M | 727M | 874M | 888M | 624M |
| EBITDA | - | - | - | 831M | 1.11B | 1.12B | 701M |
| Net Income | - | - | 441M | 477M | 683M | 598M | 165M |
| EPS | - | - | 0.71 | 0.77 | 1.08 | 0.96 | 0.27 |
| Balance Sheet | |||||||
| Total Assets | - | - | 6.69B | 7.24B | 10.7B | 10.9B | 10.7B |
| Total Liabilities | - | - | 2.21B | 2.30B | 4.48B | 4.25B | 3.88B |
| Shareholders' Equity | - | - | 4.46B | 4.93B | 6.23B | 6.65B | 6.77B |
| Cash & Short-term Investments | - | - | 707M | 854M | 550M | 369M | 429M |
| Cash Flow | |||||||
| Operating Cash Flow | 66.8M | 160M | 426M | 685M | 783M | 707M | 950M |
| Capital Expenditure | 229M | 288M | 669M | 607M | 941M | 615M | 484M |
| Free Cash Flow | - | - | -243M | 78.5M | -158M | 92.0M | 466M |
| Ratios | |||||||
| ROE | - | - | 9.9% | 9.7% | 11.0% | 9.0% | 2.4% |
| ROA | - | - | 6.6% | 6.6% | 6.4% | 5.5% | 1.5% |
| Net Profit Margin | - | - | 19.1% | 14.9% | 16.8% | 13.5% | 4.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HYGEIA HC HLDGS DL-00001 dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | CNY 94.5M | 0.15 | 13.8% |
| 2022 | - | - | - |
| 2021 | CNY 74.1M | 0.12 | 16.8% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns HYGEIA HC HLDGS DL-00001
- Insiders 76.32%
- Institutions 9.74%
- Public & others 13.95%
- Free float 260M
HYGEIA HC HLDGS DL-00001 company profile
- Company name
- HYGEIA HC HLDGS DL-00001
- Ticker
- 50I.F
- ISIN
- KYG4712E1035
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 2,778
- Fiscal year end
- December
- Address
- Enterprise Square, Shanghai, China
- Website
- hygeia-group.com.cn
About HYGEIA HC HLDGS DL-00001
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital management services. As of February 10, 2020, it operated or managed a network of 10 oncology-focused hospitals in 7 cities in 6 Provinces in the People's Republic of China. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
HYGEIA HC HLDGS DL-00001 management
2- Ms. Huanhuan ChengExec. Director & Chief Exec. Officer
- Ren AiExec. Director & Sr. VP